Huang et al. and Wang et al. also contributed to this theory when they showed that higher rates of occurrence and poorer overall survival of patients with locally advance breast cancer patients and ovarian serous adenocarcinoma patients who had abnormal levels of serum TK1 [98, 99]. This evidence concerns the gene TK1 and breast carcinoma.